These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8906031)

  • 1. Antineoplastic effect of 1,25-dihydroxy-16-ene-23-yne-vitamin D3 analogue in transgenic mice with retinoblastoma.
    Shternfeld IS; Lasudry JG; Chappell RJ; Darjatmoko SR; Albert DM
    Arch Ophthalmol; 1996 Nov; 114(11):1396-401. PubMed ID: 8906031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antineoplastic effect and toxicity of 1,25-dihydroxy-16-ene-23-yne-vitamin D3 in athymic mice with Y-79 human retinoblastoma tumors.
    Sabet SJ; Darjatmoko SR; Lindstrom MJ; Albert DM
    Arch Ophthalmol; 1999 Mar; 117(3):365-70. PubMed ID: 10088815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antineoplastic effect of vitamin D in transgenic mice with retinoblastoma.
    Albert DM; Marcus DM; Gallo JP; O'Brien JM
    Invest Ophthalmol Vis Sci; 1992 Jul; 33(8):2354-64. PubMed ID: 1634333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity and dose-response studies of 1,25-(OH)2-16-ene-23-yne vitamin D3 in transgenic mice.
    Wilkerson CL; Darjatmoko SR; Lindstrom MJ; Albert DM
    Clin Cancer Res; 1998 Sep; 4(9):2253-6. PubMed ID: 9748146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of vitamin D analogues in treating large tumors and during prolonged use in murine retinoblastoma models.
    Albert DM; Kumar A; Strugnell SA; Darjatmoko SR; Lokken JM; Lindstrom MJ; Patel S
    Arch Ophthalmol; 2004 Sep; 122(9):1357-62. PubMed ID: 15364716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,25-Dihydroxy-16-ene-23-yne-vitamin D3 prolongs survival time of leukemic mice.
    Zhou JY; Norman AW; Chen DL; Sun GW; Uskokovic M; Koeffler HP
    Proc Natl Acad Sci U S A; 1990 May; 87(10):3929-32. PubMed ID: 2339131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local carboplatin therapy in transgenic murine retinoblastoma.
    Harbour JW; Murray TG; Hamasaki D; Cicciarelli N; Hernández E; Smith B; Windle J; O'Brien JM
    Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1892-8. PubMed ID: 8759359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D inhibits angiogenesis in transgenic murine retinoblastoma.
    Shokravi MT; Marcus DM; Alroy J; Egan K; Saornil MA; Albert DM
    Invest Ophthalmol Vis Sci; 1995 Jan; 36(1):83-7. PubMed ID: 7529753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity and dose-response studies of 1 alpha-hydroxyvitamin D2 in LH beta-Tag transgenic mice.
    Dawson DG; Gleiser J; Zimbric ML; Darjatmoko SR; Frisbie JC; Lokken JM; Lindstrom MJ; Audo I; Strugnell SA; Albert DM
    Trans Am Ophthalmol Soc; 2002; 100():125-9. PubMed ID: 12545685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma.
    Van Quill KR; Dioguardi PK; Tong CT; Gilbert JA; Aaberg TM; Grossniklaus HE; Edelhauser HF; O'Brien JM
    Ophthalmology; 2005 Jun; 112(6):1151-8. PubMed ID: 15885791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local carboplatin and radiation therapy in the treatment of murine transgenic retinoblastoma.
    Murray TG; Roth DB; O'Brien JM; Feuer W; Cicciarelli N; Markoe AM; Hernández E; Smith BJ; Windle JJ
    Arch Ophthalmol; 1996 Nov; 114(11):1385-9. PubMed ID: 8906029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D analogues increase p53, p21, and apoptosis in a xenograft model of human retinoblastoma.
    Audo I; Darjatmoko SR; Schlamp CL; Lokken JM; Lindstrom MJ; Albert DM; Nickells RW
    Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4192-9. PubMed ID: 14507860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,25-Dihydroxy-16-ene-23-yne-vitamin D3 and prostate cancer cell proliferation in vivo.
    Schwartz GG; Hill CC; Oeler TA; Becich MJ; Bahnson RR
    Urology; 1995 Sep; 46(3):365-9. PubMed ID: 7660511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3 and 1alpha,25-dihydroxy-16-ene-23-yne-20-epi-vitamin D3: analogs of 1alpha,25-dihydroxyvitamin D3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway.
    Reddy GS; Rao DS; Siu-Caldera ML; Astecker N; Weiskopf A; Vouros P; Sasso GJ; Manchand PS; Uskokovic MR
    Arch Biochem Biophys; 2000 Nov; 383(2):197-205. PubMed ID: 11185554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog.
    Aparna R; Subhashini J; Roy KR; Reddy GS; Robinson M; Uskokovic MR; Venkateswara Reddy G; Reddanna P
    J Cell Biochem; 2008 Aug; 104(5):1832-42. PubMed ID: 18348265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth inhibitory effects on human colon adenocarcinoma-derived Caco-2 cells and calcemic potential of 1 alpha,25-dihydroxyvitamin D3 analogs: structure-function relationships.
    Bischof MG; Redlich K; Schiller C; Chirayath MV; Uskokovic M; Peterlik M; Cross HS
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1254-60. PubMed ID: 8531089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity and dose-response studies of 1-alpha hydroxyvitamin D2 in LH-beta-tag transgenic mice.
    Dawson DG; Gleiser J; Zimbric ML; Darjatmoko SR; Lindstrom MJ; Strugnell SA; Albert DM
    Ophthalmology; 2003 Apr; 110(4):835-9. PubMed ID: 12689912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trilateral retinoblastoma in transgenic mice.
    O'Brien JM; Marcus DM; Niffenegger AS; Bernards R; Carpenter JL; Windle JJ; Mellon P; Albert DM
    Trans Am Ophthalmol Soc; 1989; 87():301-22; discussion 322-6. PubMed ID: 2576479
    [No Abstract]   [Full Text] [Related]  

  • 19. Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3.
    Shabahang M; Buras RR; Davoodi F; Schumaker LM; Nauta RJ; Uskokovic MR; Brenner RV; Evans SR
    Cancer Res; 1994 Aug; 54(15):4057-64. PubMed ID: 8033137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel in the treatment of retinal tumors of LH beta-Tag murine transgenic model of retinoblastoma.
    Suárez F; Jockovich ME; Hernandez E; Feuer W; Parel JM; Murray TG
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3437-40. PubMed ID: 17652710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.